TickerFacts.

Guardant Health, Inc. (GH): Share Repurchases

Annual figures by period end, from SEC filings.

$45.01M
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
2016-12-31: $100.0K2017-12-31: $7.22M2018-12-31: $172.0K2019-12-31: $02020-12-31: $02023-12-31: $02024-12-31: $02025-12-31: $45.01M$45.01M
2016-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$45.01Mn/a2026-02-19, From 2025-01-01
2024-12-31$0n/a2026-02-19, From 2024-01-01
2023-12-31$0n/a2026-02-19, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31$0n/a2021-02-25, From 2020-01-01
2019-12-31$0-100.0%2021-02-25, From 2019-01-01
2018-12-31$172.0K-97.6%2021-02-25, From 2018-01-01
2017-12-31$7.22Mn/m2020-03-02, From 2017-01-01
2016-12-31$100.0Kn/a2019-03-19, From 2016-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Guardant Health, Inc. (GH)2025-12-31$45.01Mn/a
Caris Life Sciences, Inc. (CAI)2025-12-31$113.0Kn/a
CareDx, Inc. (CDNA)2025-12-31$87.77Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31$10.88Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$0-100.0%
Quest Diagnostics Inc (DGX)2025-12-31$450.00M+198.0%
Labcorp Holdings Inc. (LH)2025-12-31$450.00M+79.9%

Compare GH, CAI, CDNA, FLGT side by side · Screen every company in Services-Medical Laboratories ↗